Pharmacokinetic Comparisons of Two Donepezil Formulations
Status:
Completed
Trial end date:
2008-05-01
Target enrollment:
Participant gender:
Summary
To compare the relative bioavailability and pharmacokinetic characteristics of a newly
developed donepezil formulation with a conventional formulation in healthy subjects with a
single dose, randomized, open-label, 2-sequence -2period crossover study.